Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bioventus (BVS) EBITDA Margin (2020 - 2025)

Historic EBITDA Margin for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to 1.94%.

  • Bioventus' EBITDA Margin rose 57400.0% to 1.94% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.73%, marking a year-over-year increase of 114600.0%. This contributed to the annual value of 8.38% for FY2024, which is 295900.0% up from last year.
  • Bioventus' EBITDA Margin amounted to 1.94% in Q3 2025, which was up 57400.0% from 7.36% recorded in Q2 2025.
  • In the past 5 years, Bioventus' EBITDA Margin registered a high of 29.08% during Q2 2021, and its lowest value of 145.97% during Q2 2023.
  • Moreover, its 5-year median value for EBITDA Margin was 5.29% (2023), whereas its average is 17.86%.
  • Its EBITDA Margin has fluctuated over the past 5 years, first plummeted by -1331100bps in 2023, then soared by 1405900bps in 2024.
  • Bioventus' EBITDA Margin (Quarter) stood at 0.24% in 2021, then tumbled by -28709bps to 70.47% in 2022, then soared by 92bps to 5.29% in 2023, then surged by 86bps to 0.74% in 2024, then soared by 364bps to 1.94% in 2025.
  • Its EBITDA Margin was 1.94% in Q3 2025, compared to 7.36% in Q2 2025 and 2.17% in Q1 2025.